The company did not take precautions to minimize contamination during all processing prior to sterilization.
Inspection Record
Baxter Corporation — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The testing or examination of packaging materials was inadequate on a sample received on the premises by a person that packages the drugs.
The design, location, and/or maintenance of the equipment was inadequate for allowing the equipment to serve its intended purpose
The premises were not designed, constructed, operated, and/or maintained to prevent contamination.
The recorded information or details were inadequate.
The company's visual inspection of filled containers was inadequate.
The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.
Critical processes and procedures were not evaluated on a regular basis. Evaluation of production processes, equipment, and/or materials was inadequate.
The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.
Each container of a lot of raw materials was not tested to identify its contents with a specific, discriminating test. The sampling plan for raw materials was inadequate.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Grifols Canada Therapeutics Inc.2024-07-08 · Health CanadaSimilar to finding 1 The company did not take precautions to minimize contamination during all processing prior to sterilization.
- Cerapie Pharma Inc.2026-07-21 · Health CanadaSimilar to finding 8 The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.
- 3DM Group (Division of 171840 Canada Inc.)2026-08-11 · Health CanadaSimilar to finding 10 The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.
- Regeneron Pharmaceuticals, Inc.2026-09-15 · Health CanadaSimilar to finding 6 The recorded information or details were inadequate.
- Bonita Pharmaceuticals Inc.2026-08-13 · Health CanadaSimilar to finding 2 Investigations into deviations, reports, and/or follow-up actions were inadequate.
A record as of the Health Canada inspection on 2026-07-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.